hypoxanthine and Nervous System Disorders

hypoxanthine has been researched along with Nervous System Disorders in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Hattori, T; Ito, T; Johnson, TA; Kamatani, N; Kamitsuji, S; Koike, Y; Kume, A; Misu, K; Sobue, G; Watanabe, H	1
Kalnovicová, T; Kuracka, L; Líska, B; Turcáni, P	1
Bellini, C; Bertola, A; Bonioli, E; Caruso, U; DiStefano, A; Dorche, C; Fantasia, AR; Minniti, G; Palmieri, A	1
Basu, S; Liu, XL; Nozari, A; Ronquist, G; Rubertsson, S; Wiklund, L	1

Trials

1 trial(s) available for hypoxanthine and Nervous System Disorders

Article	Year
Improved Parkinsons disease motor score in a single-arm open-label trial of febuxostat and inosine. Medicine, 2020, Aug-28, Volume: 99, Issue:35 Topics: Adenosine Triphosphate; Administration, Oral; Aged; Case-Control Studies; Drug Therapy, Combination; Febuxostat; Female; Gout Suppressants; Humans; Hypoxanthine; Inosine; Japan; Male; Middle Aged; Nervous System Diseases; Parkinson Disease; Safety; Treatment Outcome; Xanthine Dehydrogenase	2020

Article

Year

Improved Parkinsons disease motor score in a single-arm open-label trial of febuxostat and inosine.

Medicine, 2020, Aug-28, Volume: 99, Issue:35

Topics: Adenosine Triphosphate; Administration, Oral; Aged; Case-Control Studies; Drug Therapy, Combination; Febuxostat; Female; Gout Suppressants; Humans; Hypoxanthine; Inosine; Japan; Male; Middle Aged; Nervous System Diseases; Parkinson Disease; Safety; Treatment Outcome; Xanthine Dehydrogenase

2020

Other Studies

3 other study(ies) available for hypoxanthine and Nervous System Disorders

Article	Year
HPLC method for measurement of purine nucleotide degradation products in cerebrospinal fluid. Clinical chemistry, 1996, Volume: 42, Issue:5 Topics: Adult; Brain Ischemia; Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Concentration; Hypoxanthine; Hypoxanthines; Intervertebral Disc Displacement; Middle Aged; Multiple Sclerosis; Nervous System Diseases; Purine Nucleotides; Reference Values; Subarachnoid Hemorrhage; Uric Acid; Xanthine; Xanthines	1996
Combined deficiency of xanthine oxidase and sulphite oxidase due to a deficiency of molybdenum cofactor. Journal of inherited metabolic disease, 1996, Volume: 19, Issue:5 Topics: Coenzymes; Female; Fibroblasts; Humans; Hypoxanthine; Infant; Metabolism, Inborn Errors; Metalloproteins; Molybdenum; Molybdenum Cofactors; Nervous System Diseases; Oxidoreductases Acting on Sulfur Group Donors; Pteridines; Uric Acid; Xanthine; Xanthine Oxidase; Xanthines	1996
Neurological outcome after experimental cardiopulmonary resuscitation: a result of delayed and potentially treatable neuronal injury? Acta anaesthesiologica Scandinavica, 2002, Volume: 46, Issue:5 Topics: Angioplasty, Balloon, Coronary; Animals; Cardiopulmonary Resuscitation; Cerebrovascular Circulation; Cyclosporine; Dinoprost; Epinephrine; Free Radical Scavengers; Heart Arrest; Hypoxanthine; Lactic Acid; Nervous System Diseases; Saline Solution, Hypertonic; Swine; Treatment Outcome; Vasoconstrictor Agents; Vasopressins; Xanthine	2002